Market Overview:
The global shingles treatments market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of shingles, rising awareness about available treatment options, and growing demand for home-based care. The global shingles treatments market is segmented on the basis of type into oral and tablets. The oral segment is expected to account for a larger share of the market than the tablet segment during the forecast period. This can be attributed to factors such as ease of use and lower cost as compared with other treatment options. On the basis of application, the global shingles treatments market is divided into clinics, hospitals, diagnostic centres, and home care settings.
Product Definition:
Shingles treatments are medical procedures that are used to reduce the symptoms of shingles and to speed up the healing process. Shingles treatments may include antiviral medications, pain medications, and skin creams.
Oral:
Oral is a medication that is prescribed for the treatment of shingles (herpes zoster). The active ingredient in oral drug formulations helps reduce the pain, inflammation and itching associated with shingles. It also helps improve the skin's function by reducing wrinkles and lines on the skin. Currently, there are two drugs approved by FDA to treat herpes zoster; Diflucan (fluconazole) and Valtrex (valacyclovir).
Tablets:
Tablets are small solid or liquid substances used as a drug for the treatment of diseases. They can be used individually or in combination with other drugs. Tablets are available in different forms such as film, oral, and effervescent among others.
Application Insights:
Based on the application, the global shingles treatments market is segmented into clinics, hospitals, diagnostic centers and home care settings. The clinics segment dominated the overall market in terms of revenue in 2017 owing to a rise in demand for less invasive procedures that do not require an overnight stay at hospital. In addition, an increase in travel activities across various regions has led to a significant rise in cases of chickenpox being transported for treatment at hospitals. As such, there has been a surge in demand for shingles treatments during this period.
The home care settings segment is expected to grow significantly over the forecast period due to rising awareness about availability of effective and less expensive treatment options than those offered by healthcare professionals or institutions. Furthermore, increasing prevalence rates coupled with high unmet needs regarding management of chickenpox are anticipated to boost growth over the forecast period as well as drive innovation and new product development within this sector over next eight years (2018-2030).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing home construction and replacement activities, which are driving demand for roofing systems in this region. In addition, growing awareness regarding building a healthy living environment is anticipated to fuel product demand over the forecast period.
Asia Pacific is expected to witness significant growth over the next eight years owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China and India, thereby boosting treatment adoption rates of shingles & Herpes Zoster vaccine simultaneously (acute varicella zoster virus infection). Moreover, favorable government initiatives coupled with increasing R&D investments by private companies are also contributing toward market growth across this region.
Growth Factors:
- Increasing incidence of shingles
- Growing awareness about available treatments for shingles
- Rising demand for better and more effective treatments for shingles
- Technological advancements in the field of shingle treatments
- Availability of government funding and support for research and development in the field of shingle treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Shingles Treatments Market Research Report
By Type
Oral, Tablets
By Application
Clinics, Hospitals, Diagnostic Centres, Home Care Settings
By Companies
Astellas Pharma, Foamix, Novartis, Roche, GlaxoSmithKline, Epiphany Biosciences, Merck, Beijing Minhai Biotechnology, GeneOne Life Science, NAL Pharmaceuticals, TSRL
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Shingles Treatments Market Report Segments:
The global Shingles Treatments market is segmented on the basis of:
Types
Oral, Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Diagnostic Centres, Home Care Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Astellas Pharma
- Foamix
- Novartis
- Roche
- GlaxoSmithKline
- Epiphany Biosciences
- Merck
- Beijing Minhai Biotechnology
- GeneOne Life Science
- NAL Pharmaceuticals
- TSRL
Highlights of The Shingles Treatments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Tablets
- By Application:
- Clinics
- Hospitals
- Diagnostic Centres
- Home Care Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Shingles Treatments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Shingles is a painful skin condition caused by the varicella zoster virus. It can cause pain, itching, and blisters on one or more sides of the body. Treatment usually includes antiviral medications and pain relief. In some cases, surgery may be necessary to remove the lesions.
Some of the major companies in the shingles treatments market are Astellas Pharma, Foamix, Novartis, Roche, GlaxoSmithKline, Epiphany Biosciences, Merck, Beijing Minhai Biotechnology, GeneOne Life Science, NAL Pharmaceuticals, TSRL.
The shingles treatments market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Shingles Treatments Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Shingles Treatments Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Shingles Treatments Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Shingles Treatments Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Shingles Treatments Market Size & Forecast, 2020-2028
4.5.1 Shingles Treatments Market Size and Y-o-Y Growth
4.5.2 Shingles Treatments Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Tablets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Diagnostic Centres
6.2.4 Home Care Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Shingles Treatments Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Shingles Treatments Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Tablets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Diagnostic Centres
9.10.4 Home Care Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Tablets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Diagnostic Centres
10.10.4 Home Care Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Tablets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Diagnostic Centres
11.10.4 Home Care Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Tablets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Diagnostic Centres
12.10.4 Home Care Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Tablets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Diagnostic Centres
13.10.4 Home Care Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Shingles Treatments Market: Competitive Dashboard
14.2 Global Shingles Treatments Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Astellas Pharma
14.3.2 Foamix
14.3.3 Novartis
14.3.4 Roche
14.3.5 GlaxoSmithKline
14.3.6 Epiphany Biosciences
14.3.7 Merck
14.3.8 Beijing Minhai Biotechnology
14.3.9 GeneOne Life Science
14.3.10 NAL Pharmaceuticals
14.3.11 TSRL
